246 related articles for article (PubMed ID: 26512021)
1. Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage.
Lundblad C; Haanes KA; Grände G; Edvinsson L
J Headache Pain; 2015; 16():91. PubMed ID: 26512021
[TBL] [Abstract][Full Text] [Related]
2. Dural administration of inflammatory soup or Complete Freund's Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion.
Lukács M; Haanes KA; Majláth Z; Tajti J; Vécsei L; Warfvinge K; Edvinsson L
J Headache Pain; 2015; 16():564. PubMed ID: 26329487
[TBL] [Abstract][Full Text] [Related]
3. Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72).
Lukács M; Warfvinge K; Tajti J; Fülöp F; Toldi J; Vécsei L; Edvinsson L
J Headache Pain; 2017 Dec; 18(1):39. PubMed ID: 28337634
[TBL] [Abstract][Full Text] [Related]
4. KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1β in the rat trigeminal ganglion.
Lukács M; Warfvinge K; Kruse LS; Tajti J; Fülöp F; Toldi J; Vécsei L; Edvinsson L
J Headache Pain; 2016 Dec; 17(1):64. PubMed ID: 27377707
[TBL] [Abstract][Full Text] [Related]
5. Trigeminal activation patterns evoked by chemical stimulation of the dura mater in rats.
Laborc KF; Spekker E; Bohár Z; Szűcs M; Nagy-Grócz G; Fejes-Szabó A; Vécsei L; Párdutz Á
J Headache Pain; 2020 Aug; 21(1):101. PubMed ID: 32799798
[TBL] [Abstract][Full Text] [Related]
6. Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia.
Fried NT; Maxwell CR; Elliott MB; Oshinsky ML
Cephalalgia; 2018 Apr; 38(4):674-689. PubMed ID: 28457145
[TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion.
Csáti A; Edvinsson L; Vécsei L; Toldi J; Fülöp F; Tajti J; Warfvinge K
J Headache Pain; 2015; 16():99. PubMed ID: 26627709
[TBL] [Abstract][Full Text] [Related]
8. The effect of orofacial complete Freund's adjuvant treatment on the expression of migraine-related molecules.
Körtési T; Tuka B; Nyári A; Vécsei L; Tajti J
J Headache Pain; 2019 Apr; 20(1):43. PubMed ID: 31035923
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-induced increase in hyperpolarization-activated, cyclic nucleotide-gated channel protein in trigeminal ganglion neurons and the effect of buprenorphine.
Cho HJ; Staikopoulos V; Furness JB; Jennings EA
Neuroscience; 2009 Aug; 162(2):453-61. PubMed ID: 19409968
[TBL] [Abstract][Full Text] [Related]
10. Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment.
Reducha PV; Bömers JP; Edvinsson L; Haanes KA
Front Neurol; 2023; 14():1082176. PubMed ID: 36908624
[TBL] [Abstract][Full Text] [Related]
11. Glial interleukin-1β upregulates neuronal sodium channel 1.7 in trigeminal ganglion contributing to temporomandibular joint inflammatory hypernociception in rats.
Zhang P; Bi RY; Gan YH
J Neuroinflammation; 2018 Apr; 15(1):117. PubMed ID: 29678208
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in inflammatory mediator concentrations in an adjuvant model of temporomandibular joint inflammation.
Spears R; Dees LA; Sapozhnikov M; Bellinger LL; Hutchins B
J Orofac Pain; 2005; 19(1):34-40. PubMed ID: 15779537
[TBL] [Abstract][Full Text] [Related]
13. Models of inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat.
Fehrenbacher JC; Vasko MR; Duarte DB
Curr Protoc Pharmacol; 2012 Mar; Chapter 5():Unit5.4. PubMed ID: 22382999
[TBL] [Abstract][Full Text] [Related]
14. Episodic dural stimulation in awake rats: a model for recurrent headache.
Oshinsky ML; Gomonchareonsiri S
Headache; 2007; 47(7):1026-36. PubMed ID: 17635594
[TBL] [Abstract][Full Text] [Related]
15. Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)-Induced Edema and Hypersensitivity in the Rat.
McCarson KE; Fehrenbacher JC
Curr Protoc; 2021 Jul; 1(7):e202. PubMed ID: 34314105
[TBL] [Abstract][Full Text] [Related]
16. The role of TRPM2 in hydrogen peroxide-induced expression of inflammatory cytokine and chemokine in rat trigeminal ganglia.
Chung MK; Asgar J; Lee J; Shim MS; Dumler C; Ro JY
Neuroscience; 2015 Jun; 297():160-9. PubMed ID: 25849615
[TBL] [Abstract][Full Text] [Related]
17. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.
Lacković Z; Filipović B; Matak I; Helyes Z
Br J Pharmacol; 2016 Jan; 173(2):279-91. PubMed ID: 26493010
[TBL] [Abstract][Full Text] [Related]
18. Orofacial operant behaviors and electrophysiological properties of trigeminal ganglion neurons following masseter muscle inflammation in rats.
Viatchenko-Karpinski V; Erol F; Ling J; Reed W; Gu JG
Neurosci Lett; 2019 Feb; 694():208-214. PubMed ID: 30503926
[TBL] [Abstract][Full Text] [Related]
19. Expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in the rat dental pulp and trigeminal ganglion following inflammation.
Yang ES; Jin MU; Hong JH; Kim YS; Choi SY; Kim TH; Cho YS; Bae YC
PLoS One; 2014; 9(10):e109723. PubMed ID: 25290694
[TBL] [Abstract][Full Text] [Related]
20. The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.
Lambert GA; Davis JB; Appleby JM; Chizh BA; Hoskin KL; Zagami AS
Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):311-25. PubMed ID: 19690836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
